Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 14, 2015; 21(14): 4373-4378
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4373
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4373
No. | Age (yr) | Gender | Diagnosis | Symptom grade | Symptom onset | CRP levels (Normal 0-3 mg/L) |
Case 1 | 63 | Female | Nasal Mucosa Melanoma | 3 → 4 | 6 wk | 108 |
Case 2 | 38 | Male | Back Skin Melanoma | 1 → 2 | 4 wk | 137 |
Case 3 | 71 | Female | Facial Melanoma | 2 → 4 | 5 wk | 38.3 (< 2.9 ten days after first infliximab infusion) |
Case 4 | 44 | Female | Right Inguinal Melanoma | 3 | 9 wk | 55.7 |
Case 5 | 66 | Male | Prostate Cancer, Melanoma | 3 | 3 wk | 34.7 (< 2.9 eight days following first dose methylprednisolone) |
Case 6 | 67 | Male | Right Forearm Melanoma | 3 | 18 wk | NA |
Case 7 | 55 | Male | Back Skin Melanoma | 4 | 4 wk | 97.4 |
- Citation: Rastogi P, Sultan M, Charabaty AJ, Atkins MB, Mattar MC. Ipilimumab associated colitis: An IpiColitis case series at MedStar Georgetown University Hospital. World J Gastroenterol 2015; 21(14): 4373-4378
- URL: https://www.wjgnet.com/1007-9327/full/v21/i14/4373.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i14.4373